Literature DB >> 20686821

Growth curve analysis of asymptomatic and symptomatic meningiomas.

Satoshi Nakasu1, Yoko Nakasu, Tadateru Fukami, Junya Jito, Kazuhiko Nozaki.   

Abstract

Meningiomas sometimes appear to stop growing after attaining a large size. Commonly used exponential growth models do not reflect this phenomenon. We attempted to find the best curve to simulate their growth. Fifty-two patients with meningioma were followed up for 3.1-21.7 years (mean 7.5 years) with four or more imaging studies each. Thirty-one patients had asymptomatic tumors. The other 21 patients with residual or recurrent tumor were followed up after surgery. Time-volume curves for each tumor were plotted. Nonlinear regression analyses were performed against power, exponential, logistic, and Gompertzian curves. Time-volume curves corresponded to the Gompertzian and logistic growth curves better than to power or exponential curves. When simulating time-volume curves with Gompertzian curves, the majority of benign meningiomas began to slow their growth before patient age of 80 years. Twenty-three of 31 asymptomatic meningiomas had already passed the inflection point before diagnosis. In contrast, this happened less frequently in symptomatic tumors. Especially, all six atypical meningiomas continued to grow quasi-exponentially. Sigmoid curves that approach a plateau were better descriptors of the growth of benign meningiomas than were curves of unlimited growth. However, atypical meningiomas were unlikely to slow their growth.

Entities:  

Mesh:

Year:  2010        PMID: 20686821     DOI: 10.1007/s11060-010-0319-1

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  34 in total

1.  Predicting the course of Gompertzian growth.

Authors:  L Norton; R Simon; H D Brereton; A E Bogden
Journal:  Nature       Date:  1976-12-09       Impact factor: 49.962

2.  Indications for surgery in patients with asymptomatic meningiomas based on an extensive experience.

Authors:  Shigetoshi Yano; Jun-ichi Kuratsu
Journal:  J Neurosurg       Date:  2006-10       Impact factor: 5.115

3.  A Gompertzian model of human breast cancer growth.

Authors:  L Norton
Journal:  Cancer Res       Date:  1988-12-15       Impact factor: 12.701

4.  Volumetric analysis of the growth rate of incompletely resected intracranial meningiomas.

Authors:  M Nakamura; F Roser; J Michel; C Jacobs; M Samii
Journal:  Zentralbl Neurochir       Date:  2005-02

5.  Potential doubling time and tumour doubling time in meningiomas and neurinomas.

Authors:  S Nakasu; Y Nakasu; M Nakajima; M Yokoyama; M Matsuda; J Handa
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

6.  A unified model of sigmoid tumour growth based on cell proliferation and quiescence.

Authors:  F Kozusko; M Bourdeau
Journal:  Cell Prolif       Date:  2007-12       Impact factor: 6.831

7.  A stochastic numerical model of breast cancer growth that simulates clinical data.

Authors:  J F Speer; V E Petrosky; M W Retsky; R H Wardwell
Journal:  Cancer Res       Date:  1984-09       Impact factor: 12.701

8.  Prediction of tumor doubling time in recurrent meningiomas. Cell kinetics studies with bromodeoxyuridine labeling.

Authors:  K G Cho; T Hoshino; T Nagashima; J A Murovic; C B Wilson
Journal:  J Neurosurg       Date:  1986-12       Impact factor: 5.115

9.  Incidental meningiomas in autopsy study.

Authors:  S Nakasu; A Hirano; T Shimura; J F Llena
Journal:  Surg Neurol       Date:  1987-04

Review 10.  The growth rate of human tumours.

Authors:  G G Steel; L F Lamerton
Journal:  Br J Cancer       Date:  1966-03       Impact factor: 7.640

View more
  19 in total

1.  On the probability of random genetic mutations for various types of tumor growth.

Authors:  Cristian Tomasetti
Journal:  Bull Math Biol       Date:  2012-02-07       Impact factor: 1.758

2.  Bridging population and tissue scale tumor dynamics: a new paradigm for understanding differences in tumor growth and metastatic disease.

Authors:  Sylvia Plevritis; Alexander R A Anderson; Jill Gallaher; Aravind Babu
Journal:  Cancer Res       Date:  2014-01-09       Impact factor: 12.701

3.  Mathematical Models for Tumor Growth and the Reduction of Overtreatment.

Authors:  Berdine L Heesterman; John-Melle Bokhorst; Lisa M H de Pont; Berit M Verbist; Jean-Pierre Bayley; Andel G L van der Mey; Eleonora P M Corssmit; Frederik J Hes; Peter Paul G van Benthem; Jeroen C Jansen
Journal:  J Neurol Surg B Skull Base       Date:  2018-07-23

4.  Growth dynamics of untreated glioblastomas in vivo.

Authors:  Anne Line Stensjøen; Ole Solheim; Kjell Arne Kvistad; Asta K Håberg; Øyvind Salvesen; Erik Magnus Berntsen
Journal:  Neuro Oncol       Date:  2015-03-10       Impact factor: 12.300

Review 5.  Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review.

Authors:  Leland Rogers; Igor Barani; Marc Chamberlain; Thomas J Kaley; Michael McDermott; Jeffrey Raizer; David Schiff; Damien C Weber; Patrick Y Wen; Michael A Vogelbaum
Journal:  J Neurosurg       Date:  2015-01       Impact factor: 5.115

6.  Tumor doubling time as preoperative predictor of malignancy and recurrence in newly diagnosed meningioma.

Authors:  Yusuke Miwa; Takashi Sugawara; Daisuke Kobayashi; Taketoshi Maehara
Journal:  Neurosurg Rev       Date:  2022-09-22       Impact factor: 2.800

7.  Early postoperative growth in non-functioning pituitary adenomas; A tool to tailor safe follow-up.

Authors:  Kristin Astrid Øystese; Manuela Zucknick; Olivera Casar-Borota; Geir Ringstad; Jens Bollerslev
Journal:  Endocrine       Date:  2017-05-17       Impact factor: 3.633

8.  Imaging and diagnostic advances for intracranial meningiomas.

Authors:  Raymond Y Huang; Wenya Linda Bi; Brent Griffith; Timothy J Kaufmann; Christian la Fougère; Nils Ole Schmidt; Jöerg C Tonn; Michael A Vogelbaum; Patrick Y Wen; Kenneth Aldape; Farshad Nassiri; Gelareh Zadeh; Ian F Dunn
Journal:  Neuro Oncol       Date:  2019-01-14       Impact factor: 12.300

9.  A prospective study of the natural history of incidental meningioma-Hold your horses!

Authors:  Maziar Behbahani; Geir Olve Skeie; Geir Egil Eide; Annbjørg Hausken; Morten Lund-Johansen; Bente Sandvei Skeie
Journal:  Neurooncol Pract       Date:  2019-04-17

10.  The growth rate and clinical outcomes of radiation induced meningioma undergoing treatment or active monitoring.

Authors:  Conor S Gillespie; Abdurrahman I Islim; Basel A Taweel; Christopher P Millward; Siddhant Kumar; Nitika Rathi; Shaveta Mehta; Brian J Haylock; Nicola Thorp; Catherine E Gilkes; David D A Lawson; Samantha J Mills; Emmanuel Chavredakis; Jibril Osman Farah; Andrew R Brodbelt; Michael D Jenkinson
Journal:  J Neurooncol       Date:  2021-04-22       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.